newsfilter
← Latest News
GlobeNewswire·

Biodexa issues letter to Shareholders

May 14, 2026 Biodexa issues letter to Shareholders Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), a clinical stage biopharmaceutical company developing innovative products focused on the treatment or prevention of